WAVE LIFE SCIENCES LTD. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $593.00K, a 34.16% increase year-over-year.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $439.00K, a 41.61% increase year-over-year.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $442.00K, a 26.65% increase year-over-year.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $310.00K, a 2.82% decline year-over-year.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $881.00K, a 33.69% increase from fiscal 2024.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $659.00K, a 11.90% decline from fiscal 2023.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $748.00K, a 101.08% increase from fiscal 2022.
- WAVE LIFE SCIENCES LTD. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $372.00K, a 38.82% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $593.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $881.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $439.00K 10-Q · filed 2025-11-10 | |
| 2025-03-31 | $442.00K 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $659.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $310.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $349.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $748.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $319.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $429.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $372.00K 10-K · filed 2025-03-04 | |
| 2022-09-30 | $198.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $174.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $608.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $272.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $336.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $171.00K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $171.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |